Global Ophthalmic Drugs Market Research Report 2021

SKU ID : QYR- 17225754

Publishing Date : 20-Jan-2021

No. of pages : 118

PRICE
2900
5800


  • Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
    The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.

    The global Ophthalmic Drugs market was valued at US$ 22440 million in 2019 and is expected to reach US$ 26300 million by the end of 2026, growing at a CAGR of 2.3% during 2021-2026.
    This report focuses on Ophthalmic Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ophthalmic Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

    Global Ophthalmic Drugs Market: Segment Analysis
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Anti-allergy
    Anti-VEGF Agents
    Anti-inflammatory
    Anti-glaucoma

    Segment by Application
    Hospital
    Clinic
    Pharmacy

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Santen Pharmaceutical
    Bausch Health
    Takeda
    Novartis
    Genentech
    Allergan
    Sun Pharmaceutical Industries
    Actavis Generics
    Regeneron Pharmaceuticals
    Pfizer
    Johnson and Johnson
    Bausch and Lomb

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports